SOLIDARITY Finland Plus Long-COVID Adults (18-64 years) General population Elderly (≥65 years) Hospital Intensive care unit SARS-CoV-2 Post-COVID-19 Pharmacological intervention Monoclonal antibodies Immunomodulator Antineoplastic agent Imatinib Infliximab